Home
VNDA
VNDA News

Latest Vanda Pharmaceuticals Inc. (VNDA) News on July 26, 2024

Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024

PR Newswire

10 hours ago

Vanda Pharmaceuticals to Announce Second Quarter 2024 Financial Results on July 31, 2024

MT Newswires

25 days ago

Vanda Pharmaceuticals Says Federal Court Allows Patent Lawsuit Over Hetlioz

Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex

PR Newswire

25 days ago

Federal Court Allows Vanda's HETLIOZ® Patent Lawsuit to Proceed against Teva and Apotex

Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs

BioPharma Dive

a month ago

Jazz drug for tremor fails study; Radiopharma drug developer ITM swaps CEOs

Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders

PR Newswire

a month ago

Vanda Pharmaceuticals Board of Directors Determines that Recent Unsolicited Takeover Proposals Are Not in the Best Interests of the Company and its Shareholders

MT Newswires

a month ago

Sector Update: Health Care Stocks Ease Late Afternoon

MT Newswires

a month ago

Sector Update: Health Care Stocks Softer Thursday Afternoon

MT Newswires

a month ago

Sector Update: Health Care

MT Newswires

a month ago

Vanda Pharmaceuticals Receives Revised Offer From Future Pak; Shares Rise

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak

PR Newswire

a month ago

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak

Cycle Pharmaceuticals offers to acquire Vanda Pharma for $466m

Pharmaceutical Technology

2 months ago

Cycle Pharmaceuticals offers to acquire Vanda Pharma for $466m

Vanda (VNDA) Surges 24.2%: Is This an Indication of Further Gains?

Zacks

2 months ago

Vanda (VNDA) Surges 24.2%: Is This an Indication of Further Gains?

MT Newswires

2 months ago

Sector Update: Health Care Stocks Higher in Late Afternoon Trading

MT Newswires

2 months ago

Sector Update: Health Care Stocks Advance Thursday Afternoon

MT Newswires

2 months ago

Sector Update: Health Care

MT Newswires

2 months ago

Vanda Pharmaceuticals' Shares Rally After Company Receives $466 Million Buyout Offer From Cycle Pharma

Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.

PR Newswire

2 months ago

Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd.

MT Newswires

2 months ago

Cycle Pharmaceuticals Offers to Buy Vanda Pharmaceuticals for $466 Million

MT Newswires

2 months ago

Top Premarket Gainers

MT Newswires

2 months ago

Vanda Pharmaceuticals to Commercialize Treatment of Multiple Sclerosis in the US

Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference

PR Newswire

2 months ago

Vanda Pharmaceuticals Announces Participation in the Jefferies 2024 Global Healthcare Conference

Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®

PR Newswire

2 months ago

Vanda Pharmaceuticals Announces Completion of Transfer of FDA Marketing Authorization for PONVORY®

Vanda Pharmaceuticals Announces Presentations at SLEEP 2024

PR Newswire

2 months ago

Vanda Pharmaceuticals Announces Presentations at SLEEP 2024

Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders

PR Newswire

2 months ago

Vanda Pharmaceuticals Board of Directors Determines that Revised Unsolicited Takeover Proposal is Not in the Best Interests of the Company and its Shareholders

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study

Zacks

2 months ago

Vanda (VNDA) Rises on Positive Data From Motion Sickness Study

Vanda Pharmaceuticals reports positive data from motion sickness trial

Clinical Trials Arena

2 months ago

Vanda Pharmaceuticals reports positive data from motion sickness trial

MT Newswires

2 months ago

Vanda Pharmaceuticals Says Second Phase 3 Study of Tradipitant in Motion Sickness Yields 'Positive' Results

Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness

PR Newswire

2 months ago

Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness

Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue Estimates

GuruFocus.com

3 months ago

Vanda Pharmaceuticals Reports Mixed Q1 2024 Results, Misses Revenue Estimates

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript

Insider Monkey

3 months ago

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q1 2024 Earnings Call Transcript

Thomson Reuters StreetEvents

3 months ago

Q1 2024 Vanda Pharmaceuticals Inc Earnings Call

GuruFocus.com

3 months ago

Vanda Pharmaceuticals Inc (VNDA) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...

Associated Press Finance

3 months ago

Vanda: Q1 Earnings Snapshot

Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results

PR Newswire

3 months ago

Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results

MT Newswires

3 months ago

Vanda Pharmaceuticals Shares Rise After Future Pak Adds $260 Million Potential Payments to Cash Offer

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak

PR Newswire

3 months ago

Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak

Reuters

3 months ago

UPDATE 3-Future Pak sweetens take-private offer for Vanda Pharmaceuticals

Reuters

3 months ago

Future Pak increases buyout offer for Vanda Pharmaceuticals

Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024

PR Newswire

3 months ago

Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024

Reuters

3 months ago

UPDATE 1-Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer

Reuters

3 months ago

Shareholder Capital asks Vanda Pharma's board to reconsider Future Pak's offer

GlobeNewswire

3 months ago

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals

Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know

Zacks

3 months ago

Vanda Pharmaceuticals (VNDA) Stock Sinks As Market Gains: What You Should Know

Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?

Zacks

3 months ago

Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?

Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation

PR Newswire

3 months ago

Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation

MT Newswires

3 months ago

Vanda Pharmaceuticals Appeal for Patents on Sleep Drug Declined by US Supreme Court

Reuters

3 months ago

UPDATE 1-U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents

U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents

Reuters

3 months ago

U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents

Reuters

3 months ago

U.S. Supreme Court rejects Vanda Pharmaceuticals case over sleep-drug patents

Reuters

3 months ago

Butler Hall Capital urges Vanda to engage in sales discussions

Vanda (VNDA) Rejects Takeover Interest From Future Pak, Stock Up

Zacks

3 months ago

Vanda (VNDA) Rejects Takeover Interest From Future Pak, Stock Up

Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here is What You Need to Know

Zacks

3 months ago

Investors Heavily Search Vanda Pharmaceuticals Inc. (VNDA): Here is What You Need to Know

Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share

Benzinga

3 months ago

Neuropsychiatric-Focused Vanda Pharmaceuticals Rejects Future Pak's Takeover Bid Valued Up To $7.75/Share

Why Vanda Pharmaceuticals Stock Is Skyrocketing Today

Motley Fool

3 months ago

Why Vanda Pharmaceuticals Stock Is Skyrocketing Today

Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan

PR Newswire

3 months ago

Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan

Reuters

3 months ago

Vanda Pharmaceuticals rejects takeover proposal from Future Pak

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak

PR Newswire

3 months ago

Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak

Vanda Pharmaceuticals (VNDA) Declines More Than Market: Some Information for Investors

Zacks

3 months ago

Vanda Pharmaceuticals (VNDA) Declines More Than Market: Some Information for Investors

Vanda Pharmaceuticals (VNDA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Zacks

4 months ago

Vanda Pharmaceuticals (VNDA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

AstraZeneca's (AZN) Enhertu Gets FDA Nod for Solid Tumors

Zacks

4 months ago

AstraZeneca's (AZN) Enhertu Gets FDA Nod for Solid Tumors

Vanda (VNDA) Soars 29.2%: Is Further Upside Left in the Stock?

Zacks

4 months ago

Vanda (VNDA) Soars 29.2%: Is Further Upside Left in the Stock?

Vanda (VNDA) Up on FDA Nod for Fanapt in Bipolar I Disorder

Zacks

4 months ago

Vanda (VNDA) Up on FDA Nod for Fanapt in Bipolar I Disorder

Here's Why Amgen (AMGN) Stock is Outperforming the Industry

Zacks

4 months ago

Here's Why Amgen (AMGN) Stock is Outperforming the Industry

Why Is Vanda Pharmaceuticals Stock Trading Higher Today?

Benzinga

4 months ago

Why Is Vanda Pharmaceuticals Stock Trading Higher Today?

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder

PR Newswire

4 months ago

Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder

AstraZeneca (AZN) Dato-DXd Breast Cancer BLA Gets FDA Acceptance

Zacks

4 months ago

AstraZeneca (AZN) Dato-DXd Breast Cancer BLA Gets FDA Acceptance

AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod

Zacks

4 months ago

AstraZeneca's (AZN) Rare Blood Disorder Drug Gets FDA Nod

AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication

Zacks

4 months ago

AstraZeneca's (AZN) Ultomiris Gets FDA Nod for New Indication

Spruce Biosciences (SPRB) Falls 86% in a Month: Here's Why

Zacks

4 months ago

Spruce Biosciences (SPRB) Falls 86% in a Month: Here's Why

Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up

Zacks

4 months ago

Cybin (CYBN) Begins Phase II Study on Anxiety Drug, Stock Up

J&J (JNJ) Gets FDA Panel Vote for Carvykti's Expanded Use

Zacks

4 months ago

J&J (JNJ) Gets FDA Panel Vote for Carvykti's Expanded Use

Pfizer's (PFE) Adcetris Meets Survival Goal in Lymphoma Study

Zacks

4 months ago

Pfizer's (PFE) Adcetris Meets Survival Goal in Lymphoma Study

MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag

Zacks

5 months ago

MindMed's (MNMD) Anxiety Drug Gets FDA Breakthrough Therapy Tag

Vanda (VNDA) Falls on FDA's CRL to Hetlioz sNDA for Insomnia

Zacks

5 months ago

Vanda (VNDA) Falls on FDA's CRL to Hetlioz sNDA for Insomnia

Chairman of Vanda Pharmaceuticals Inc (VNDA) Sells Shares

GuruFocus.com

5 months ago

Chairman of Vanda Pharmaceuticals Inc (VNDA) Sells Shares

Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata

Zacks

5 months ago

Nektar (NKTR) Begins Phase IIb Study Rezpeg in Alopecia Areata

Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia

PR Newswire

5 months ago

Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia

Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat

Zacks

5 months ago

Nektar (NKTR) Q4 Loss Wider Than Expected, Revenue Beat

Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why

Zacks

5 months ago

Arcturus (ARCT) Stock Surges 73% in 3 Months: Here's Why

Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat

Zacks

5 months ago

Mirum's (MIRM) Q4 Earnings Lag Estimates, Revenues Beat

Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates

Zacks

5 months ago

Amicus' (FOLD) Q4 Earnings Beat, Revenues Meet Estimates

Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates

Zacks

5 months ago

Theravance's (TBPH) Q4 Earnings & Revenues Surpass Estimates

Karuna's (KRTX) Q4 Loss Widens, Focus on Bristol Myers Buyout

Zacks

5 months ago

Karuna's (KRTX) Q4 Loss Widens, Focus on Bristol Myers Buyout

Jim Simons Adds Vanda Pharmaceuticals to Portfolio in Recent Trade

GuruFocus.com

5 months ago

Jim Simons Adds Vanda Pharmaceuticals to Portfolio in Recent Trade

Earnings Estimates Moving Higher for Vanda (VNDA): Time to Buy?

Zacks

5 months ago

Earnings Estimates Moving Higher for Vanda (VNDA): Time to Buy?

News Flash: Analysts Just Made A Sizeable Upgrade To Their Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Forecasts

Simply Wall St.

6 months ago

News Flash: Analysts Just Made A Sizeable Upgrade To Their Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Forecasts

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2023 Earnings Call Transcript

Insider Monkey

6 months ago

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) Q4 2023 Earnings Call Transcript

Thomson Reuters StreetEvents

6 months ago

Q4 2023 Vanda Pharmaceuticals Inc Earnings Call

Vanda Pharmaceuticals Inc (VNDA) Faces Revenue Decline Amid Patent Challenges and Generic ...

GuruFocus.com

6 months ago

Vanda Pharmaceuticals Inc (VNDA) Faces Revenue Decline Amid Patent Challenges and Generic ...

Associated Press Finance

6 months ago

Vanda: Q4 Earnings Snapshot

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

PR Newswire

6 months ago

Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia

PR Newswire

6 months ago

Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia

Thomson Reuters StreetEvents

6 months ago

Preliminary Q4 2023 American Vanguard Corp Earnings Call

American Vanguard Confirms 2023 and 2024 Targets

Business Wire

6 months ago

American Vanguard Confirms 2023 and 2024 Targets

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

PR Newswire

6 months ago

Vanda Pharmaceuticals to Announce Fourth Quarter and Full Year 2023 Financial Results on February 7, 2024

Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VTR-297 a Topical Antifungal Candidate for the Treatment of Onychomycosis

PR Newswire

6 months ago

Vanda Pharmaceuticals Receives FDA Approval to Proceed with Investigational New Drug VTR-297 a Topical Antifungal Candidate for the Treatment of Onychomycosis

Court Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag Hearing Request by March 5, 2024

PR Newswire

6 months ago

Court Orders FDA to Resolve Vanda Pharmaceuticals' Jet Lag Hearing Request by March 5, 2024

What Made Laughing Water Capital Sell Vanda Pharmaceuticals (VNDA)?

Insider Monkey

6 months ago

What Made Laughing Water Capital Sell Vanda Pharmaceuticals (VNDA)?

Reuters

6 months ago

UPDATE 1-QatarEnergy, Excelerate Energy sign 15-year supply LNG deal

Reuters

6 months ago

QatarEnergy, Excelerate Energy agree deal to supply LNG to Bangladesh

Share on Social Networks: